CompanyTrack
Sign Up Log In
E

ECHOPOINT MEDICAL LTD

Active London

Manufacture of medical and dental instruments and supplies

6 employees Website
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
E

ECHOPOINT MEDICAL LTD

Manufacture of medical and dental instruments and supplies

Founded 9 Nov 2018 Active London, England 6 employees echopointmedical.com
Life sciences and medical technology Manufacture of medical and dental instruments and supplies
Accounts Submitted 13 Jun 2025
Confirmation Statement Submitted 10 Dec 2025
Net assets £3.37M £3.99M 2024 year on year
Total assets £0.00 £54.76K 2024 year on year
Total Liabilities £158.45K £516.82K 2024 year on year
Charges 1
1 outstanding

AI Analysis

AI Analysis

Analyze director networks, ownership patterns, and company connections

CompanyTrack AI can make mistakes. Check important info.

Contact & Details

Contact

Update Details

Registered Address

2nd Floor 65-69 East Road London N1 6AH England

Office (London)

16 Mortimer St, London W1T 3JL

Office (London)

90 Tottenham Court Road, London W1T 4TJ, United Kingdom

Credit Report

Discover ECHOPOINT MEDICAL LTD's Credit Score, limit, and payment likelihood.

Mutual Companies

See All Mutual Companies

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2019–2024)

Cash in Bank

£3.31M

Increased by £3.28M (+10659%)

Net Assets

£3.37M

Increased by £3.99M (+643%)

Total Liabilities

£158.45k

Decreased by £516.82k (-77%)

Turnover

N/A

Employees

6

Debt Ratio

N/A

Decreased by 1233 (-100%)
See 10 Year Full Financials

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

£890k awarded
Show:

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

8 Allotments 389,745 Shares £6.69m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
20 Mar 20255,596£100k£100k
19 Feb 2024194,773£4.29m£22
19 Feb 202439,027£601k£15.4
18 Jul 201945,455£700k£15.4
10 Apr 201964,935£1000k£15.4

Officers

Officers

7 active
Status
Adrien Emmanuel DesjardinsDirectorCanadianEngland489 Nov 2018Active
Antony Ruben OdellDirectorBritishEngland649 Nov 2018Active
Malcolm Charles FinlayDirectorBritishEngland499 Nov 2018Active
Nancy BriefsDirectorAmericanUnited States711 Oct 2024Active
Parkwalk Advisors LtdCorporate-directorUnited KingdomUnknown—18 Jul 2019Active
Ucltf Corporate Directors LtdCorporate-directorUnited KingdomUnknown—19 Feb 2024Active
Weng Sie WongDirectorBritishEngland5310 Apr 2019Active

Shareholders

Shareholders (11)

Utf General Partner Llp In Its Capacity As General Partner Of Ucl Technology Fund Lp
23.1%
112,01326 Nov 2024
Utf General Partner Llp In Its Capacity As General Partner Of Ucl Technology Fund Lp
15.2%
73,59326 Nov 2024
Ucl Business Plc
6.5%
31,30126 Nov 2024

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased

Utf General Partner Llp

United Kingdom

Active
Notified 26 Sept 2019
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Mnl (parkwalk) Nominees Limited

United Kingdom

Active
Notified 19 Feb 2024
Nature of Control
  • Ownership Of Shares 25 To 50 Percent

Adrien Emmanuel Desjardins

Ceased 26 Sept 2019

Ceased

Malcolm Charles Finlay

Ceased 26 Sept 2019

Ceased
See All Controllers

Group Structure

Group Structure

MNL (PARKWALK) NOMINEES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
UTF GENERAL PARTNER LLP united kingdom voting rights 75 to 100 percent limited liability partnership
APEX UNITAS LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
UTF ALBION MEMBER LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent
APEX VENTURES FUND SERVICES LIMITED united kingdom shares 75 to 100 percent, voting rights 75 to 100 percent, appoint/remove directors
ALBION CAPITAL GROUP LLP united kingdom
APEX CONSOLIDATION ENTITY LTD united kingdom
ECHOPOINT MEDICAL LTD Current Company

Charges

Charges

1 outstanding

Documents

Company Filings

DateCategoryDescriptionDocument
11 Dec 2025CapitalAllotment of shares (GBP 50.2332) on 2025-11-25View(4 pages)
11 Dec 2025CapitalAllotment of shares (GBP 50.2332) on 2025-11-26View(4 pages)
11 Dec 2025CapitalAllotment of shares (GBP 49.648) on 2025-11-25View(4 pages)
11 Dec 2025CapitalAllotment of shares (GBP 49.4796) on 2025-11-25View(4 pages)
10 Dec 2025OfficersTermination of Adrien Emmanuel Desjardins as director on 2025-11-07View(1 page)
11 Dec 2025 Capital

Allotment of shares (GBP 50.2332) on 2025-11-25

View Document(4 pages)
11 Dec 2025 Capital

Allotment of shares (GBP 50.2332) on 2025-11-26

View Document(4 pages)
11 Dec 2025 Capital

Allotment of shares (GBP 49.648) on 2025-11-25

View Document(4 pages)
11 Dec 2025 Capital

Allotment of shares (GBP 49.4796) on 2025-11-25

View Document(4 pages)
10 Dec 2025 Officers

Termination of Adrien Emmanuel Desjardins as director on 2025-11-07

View Document(1 page)

Recent Activity

Latest Activity

Allotment of shares (GBP 50.2332) on 2025-11-25

2 months ago on 11 Dec 2025

Allotment of shares (GBP 50.2332) on 2025-11-26

2 months ago on 11 Dec 2025

Allotment of shares (GBP 49.648) on 2025-11-25

2 months ago on 11 Dec 2025

Allotment of shares (GBP 49.4796) on 2025-11-25

2 months ago on 11 Dec 2025

Termination of Adrien Emmanuel Desjardins as director on 2025-11-07

2 months ago on 10 Dec 2025